Home › Funds › Palo Alto Investors LP › ALKS
Palo Alto Investors LP position in ALKS
ALKERMES PLC · Health Care
Palo Alto Investors LP reported holding 203,680 shares of ALKS (ALKERMES PLC) in its Q3 2026 13F filing — a position valued at US$8.3M, representing 1.23% of its reported portfolio and ranking #22 among its reported holdings. Palo Alto Investors LP has disclosed ALKS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's ALKS position evolved
Palo Alto Investors LP first disclosed a stake in ALKS in Q3 2023 at 603,400 shares (US$16.9M). Across 13 filings, Palo Alto Investors LP increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 203,680 shares valued at US$8.3M — a reduction of -38,880 shares quarter over quarter.. Notable position changes include a 32% increase in Q4 2025 (shares rose 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 603.40K | $16.90M | New |
| Q4 2023 | 603.40K | $16.74M | Hold |
| Q1 2024 | 495.59K | $13.42M | Reduce |
| Q2 2024 | 495.59K | $11.94M | Hold |
| Q3 2024 | 384.66K | $10.77M | Reduce |
| Q4 2024 | 289.31K | $8.32M | Reduce |
| Q1 2025 | 221.51K | $7.31M | Reduce |
| Q2 2025 | 221.02K | $6.32M | Hold |
| Q3 2025 | 183.94K | $5.52M | Reduce |
| Q4 2025 | 242.56K | $6.79M | Add |
| Q1 2026 | 242.56K | $8.58M | Hold |
| Q2 2026 | 242.56K | $12.71M | Hold |
| Q3 2026 | 203.68K | $8.25M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALKS and 13F data
ALKS (ALKERMES PLC) is a Health Care company. 32 other funds we track also report a position in ALKS — the largest reported positions include BAKER BROS. ADVISORS LP (US$405.7M), Renaissance Technologies (US$263.1M), Deep Track Capital, LP (US$182.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALKS
- BAKER BROS. ADVISORS LP 10.01M sh · $405.70M · Q3 2026
- Renaissance Technologies 6.49M sh · $263.13M · Q3 2026
- Deep Track Capital, LP 4.50M sh · $182.34M · Q3 2026
- Bain Capital Life Sciences Investors, LLC 3.15M sh · $127.68M · Q3 2026
- Commodore Capital LP 2.88M sh · $116.51M · Q3 2026
- BVF INC/IL 2.85M sh · $115.36M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held ALKS?
Palo Alto Investors LP has disclosed ALKS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Palo Alto Investors LP's current position in ALKS?
As of Q3 2026, Palo Alto Investors LP holds 203.68K shares of ALKS (ALKERMES PLC), valued at $8.25M, representing 1.23% of its reported portfolio and ranking #22.
Has Palo Alto Investors LP been buying or selling ALKS?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP reduced its position in ALKS.
Which other funds hold ALKS?
Other major institutional holders of ALKS include BAKER BROS. ADVISORS LP, Renaissance Technologies, Deep Track Capital, LP, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.